Hexamethyl Pararosaniline

CHEMBL459265 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
372.5 g/mol
LogP
4.9
Phase
4

This antiseptic dye, also known as crystal violet or gentian violet, has been used for decades to prevent and treat bacterial and fungal skin infections. It works by disrupting the cell membranes of microorganisms, making it effective against a broad range of pathogens.

Masse moléculaire

372,5000 g/mol

LogP

4,90

TPSA

9,50 Ų

Règle des 5 de Lipinski

Conforme

Mécanisme d'action

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1

InChI

InChI=1S/C25H30N3/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6/h7-18H,1-6H3/q+1

Molecular Formula

C25H30N3+

HBD / HBA

- / 2

Liaisons Rotatives

4

Atomes Lourds

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This antiseptic dye, also known as crystal violet or gentian violet, has been used for decades to prevent and treat bacterial and fungal skin infections. It works by disrupting the cell membranes of microorganisms, making it effective against a broad range of pathogens.

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Yes, Hexamethyl Pararosaniline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL459265. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3468. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.